US life expectancy hits record high in 2024, CDC says

US life expectancy rose to 79.0 years in 2024, up 0.6 years from 2023 and surpassing the previous record set in 2014, the CDC's National Center for Health Statistics reported; infant mortality was unchanged. The report notes life expectancy fell to 76.1 in 2021 amid the COVID-19 pandemic, nine of the top ten causes of death were unchanged with heart disease, cancer and unintentional injuries leading, suicide entering the top 10 and COVID-19 sliding to 15th — a trend that modestly improves longevity assumptions for insurers and pension liabilities but is unlikely to produce material near-term market moves.

Analysis

Market structure: A 0.6-year rise to 79 years incrementally shifts demand toward chronic-care, long-term care, Medicare Advantage and annuity products. Winners: Medicare Advantage insurers (UNH, HUM, CI) and med-tech/pharma names focused on cardiovascular and oncology (JNJ, MDT, MRK) where recurring care and device replacement increase revenue visibility; losers: select annuity-heavy life insurers (MET, PRU) that face longer-duration liabilities unless hedged. Pricing power will favor vertically integrated payers/providers with scale to manage chronic-care costs; nursing-home/assisted-living REITs (WELL, VTR) gain secular demand but remain rate-sensitive.

Risk assessment: Tail risks include accelerated regulatory price controls (drug pricing/Medicare reimbursement) or a new pandemic that reverses mortality trends; quantify: a policy move cutting Medicare Advantage margins by 200–300 bps would materially compress UNH/HUM EPS. Short-term (days–weeks) market reaction should be muted; medium-term (3–12 months) earnings/reimbursement cycles matter; long-term (years) structural pension/annuity liability growth pressures asset allocators and fixed‑income markets. Hidden dependency: reimbursement policy and interest rates drive valuation more than incremental lifespan gains.

Trade implications: Tactical overweight 6–12 month exposure to UNH/HUM (2–4% portfolio each) and 12–24 month exposure to JNJ/MDT for durable device/cardiac franchises; pair short small allocation (1–2%) in PRU or MET via put spreads to express annuity-liability sensitivity if spreads widen. Use options: buy 6–9 month ITM call spreads on UNH/HUM to limit premium with 15–25% upside targets; purchase 9–12 month put spreads on MET/PRU keyed to a 10–15% downside. Rotate out of high-duration healthcare REIT exposure if 10‑year Treasury yields rise >50 bps over 2 months; prefer operators with >60% skilled-nursing/MAPD rent exposure.

Contrarian angles: Consensus underestimates the near-term impact on behavioral health and telemedicine (suicide entering top-10) — small-cap behavioral-health platforms (TDOC-sized exposure) could re-rate if utilization accelerates by +5–10% year-over-year. Reaction is underdone for payers with strong MA footprints and overdone for vanilla life insurers that often hedge interest-rate risk; historical parallel: gradual longevity improvements (post-1950s) supported healthcare-equity outperformance vs. insurers. Unintended consequence: aggressive long bets on elderly-care REITs can blow up if rates spike; hedge with 2–4% long Treasury ETFs (IEF) if rates volatility exceeds 60-day historical by >1.5x.

Key Decisions for Investors

• Establish a 2.5% long position in UNH and a 2% long in HUM (combined ~4.5% portfolio) over the next 2–6 weeks, targeting 12–18% upside in 12 months; use 6–9 month call spreads (buy Jun calls, sell higher strike) to limit premium outlay.
• Open a 1.5% short put-spread position on MET or PRU (buy 9–12 month protective put spread) sized to 1–2% portfolio to hedge annuity-liability risk; trigger add if spread to UNH widens >150 bps or stock underperforms peer median by 10% in 30 days.
• Allocate 1.5% to JNJ or MDT for 12–24 month exposure to cardiovascular devices/oncology support; add on any pullback >7% from current levels, target 10–15% total return.
• Buy 6–12 month call spreads on select telehealth/behavioral names (e.g., TDOC-sized exposure) sized 0.5–1% portfolio if utilization metrics improve by +5% QoQ or suicide-related service volumes reported higher in upcoming quarterly data.
• Reduce exposure to high-duration healthcare REITs (WELL, VTR) by 50% if 10-year Treasury yield rises >50 bps within 60 days; hedge remaining position with 2–4% allocation to IEF if 30-day rates volatility >1.5x historical.